Data / Form D filings / PridCor Therapeutics, LLC
PridCor Therapeutics, LLC: Form D filings
PridCor Therapeutics, LLC, a pharmaceuticals company in Tuscaloosa, AL, filed 4 Form D notices with the SEC between 2025 and 2026. The latest, on July 6, 2026, reports an offering of $6 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1837 COMMONS NORTH DRIVE, Tuscaloosa, AL, 35406
- Phone
- (205) 366-0696
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Alabama
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2074593
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Amendment | $6,045,000 | $0 | $6,045,000 | 0 | Yet to occur | sec.gov |
| May 8, 2026 | New notice | $6,045,000 | $0 | $6,045,000 | 0 | Yet to occur | sec.gov |
| Feb 2, 2026 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
| Jun 25, 2025 | New notice | $40,000 | $0 | $40,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William L Pridgen | Executive Officer, Promoter | |
| Brian Corday | Executive Officer, Promoter |
Every Form D from the week of Jul 6, 2026 · All recent filings in Alabama · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PridCor Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.